- Home
- GECC vs SGHT Comparison
GECC vs SGHT Comparison
Compare GECC & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GECC
- SGHT
- Stock Information
- Founded
- GECC 2016
- SGHT 2011
- Country
- GECC United States
- SGHT United States
- Employees
- GECC N/A
- SGHT N/A
- Industry
- GECC Finance: Consumer Services
- SGHT Medical Specialities
- Sector
- GECC Finance
- SGHT Health Care
- Exchange
- GECC Nasdaq
- SGHT Nasdaq
- Market Cap
- GECC 120.9M
- SGHT 140.1M
- IPO Year
- GECC N/A
- SGHT 2021
- Fundamental
- Price
- GECC $11.12
- SGHT $2.53
- Analyst Decision
- GECC
- SGHT Buy
- Analyst Count
- GECC 0
- SGHT 7
- Target Price
- GECC N/A
- SGHT $4.68
- AVG Volume (30 Days)
- GECC 12.0K
- SGHT 195.9K
- Earning Date
- GECC 03-03-2025
- SGHT 03-05-2025
- Dividend Yield
- GECC 13.22%
- SGHT N/A
- EPS Growth
- GECC N/A
- SGHT N/A
- EPS
- GECC 0.65
- SGHT N/A
- Revenue
- GECC $39,468,000.00
- SGHT $79,543,000.00
- Revenue This Year
- GECC $17.68
- SGHT $1.23
- Revenue Next Year
- GECC $4.96
- SGHT $0.34
- P/E Ratio
- GECC $17.09
- SGHT N/A
- Revenue Growth
- GECC 16.86
- SGHT N/A
- 52 Week Low
- GECC $9.55
- SGHT $2.50
- 52 Week High
- GECC $11.34
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- GECC 65.72
- SGHT 35.62
- Support Level
- GECC $10.45
- SGHT $2.59
- Resistance Level
- GECC $11.34
- SGHT $2.87
- Average True Range (ATR)
- GECC 0.23
- SGHT 0.18
- MACD
- GECC 0.05
- SGHT 0.02
- Stochastic Oscillator
- GECC 77.25
- SGHT 6.74
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. The company seeks to generate current income and capital appreciation through debt and equity investments, including investments in specialty finance businesses. It invests in senior secured and senior unsecured debt instruments, as well as in junior loans and mezzanine debt of middle-market companies and small businesses. The company generates revenue from interest on the debt investments that it holds.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.